Bell Ceremonies

ProKidney Corp. Rings the Nasdaq Stock Market Opening Bell

Published

ProKidney Corp. (Nasdaq: PROK), a leading clinical-stage cellular therapeutics company focused on chronic kidney disease (“CKD”), visits the Nasdaq MarketSite in Times Square to commemorate the closing of its business combination with Social Capital Suvretta Holdings Corp. III. In honor of the occasion, Pablo Legorreta, Chairman, and Tim Bertram, Founder and CEO of ProKidney, rings the Opening Bell.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now